Cargando…

Exploring the unknown: assumptions about allelic architecture and strategies for susceptibility variant discovery

Identification of common-variant associations for many common disorders has been highly effective, but the loci detected so far typically explain only a small proportion of the genetic predisposition to disease. Extending explained genetic variance is one of the major near-term goals of human geneti...

Descripción completa

Detalles Bibliográficos
Autor principal: McCarthy, Mark I
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717392/
https://www.ncbi.nlm.nih.gov/pubmed/19591663
http://dx.doi.org/10.1186/gm66
_version_ 1782169887798460416
author McCarthy, Mark I
author_facet McCarthy, Mark I
author_sort McCarthy, Mark I
collection PubMed
description Identification of common-variant associations for many common disorders has been highly effective, but the loci detected so far typically explain only a small proportion of the genetic predisposition to disease. Extending explained genetic variance is one of the major near-term goals of human genetic research. Next-generation sequencing technologies offer great promise, but optimal strategies for their deployment remain uncertain, not least because we lack a clear view of the characteristics of the variants being sought. Here, I discuss what can and cannot be inferred about complex trait disease architecture from the information currently available and review the implications for future research strategies.
format Text
id pubmed-2717392
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27173922010-07-03 Exploring the unknown: assumptions about allelic architecture and strategies for susceptibility variant discovery McCarthy, Mark I Genome Med Minireview Identification of common-variant associations for many common disorders has been highly effective, but the loci detected so far typically explain only a small proportion of the genetic predisposition to disease. Extending explained genetic variance is one of the major near-term goals of human genetic research. Next-generation sequencing technologies offer great promise, but optimal strategies for their deployment remain uncertain, not least because we lack a clear view of the characteristics of the variants being sought. Here, I discuss what can and cannot be inferred about complex trait disease architecture from the information currently available and review the implications for future research strategies. BioMed Central 2009-07-03 /pmc/articles/PMC2717392/ /pubmed/19591663 http://dx.doi.org/10.1186/gm66 Text en Copyright ©2009 BioMed Central Ltd
spellingShingle Minireview
McCarthy, Mark I
Exploring the unknown: assumptions about allelic architecture and strategies for susceptibility variant discovery
title Exploring the unknown: assumptions about allelic architecture and strategies for susceptibility variant discovery
title_full Exploring the unknown: assumptions about allelic architecture and strategies for susceptibility variant discovery
title_fullStr Exploring the unknown: assumptions about allelic architecture and strategies for susceptibility variant discovery
title_full_unstemmed Exploring the unknown: assumptions about allelic architecture and strategies for susceptibility variant discovery
title_short Exploring the unknown: assumptions about allelic architecture and strategies for susceptibility variant discovery
title_sort exploring the unknown: assumptions about allelic architecture and strategies for susceptibility variant discovery
topic Minireview
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717392/
https://www.ncbi.nlm.nih.gov/pubmed/19591663
http://dx.doi.org/10.1186/gm66
work_keys_str_mv AT mccarthymarki exploringtheunknownassumptionsaboutallelicarchitectureandstrategiesforsusceptibilityvariantdiscovery